For more information about this clinical trial, please visit the following link: https://clinicaltrials.gov/study/NCT05879926
A Phase III Adjuvant Trial Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression plus Endocrine Therapy in Premenopausal Patients with pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score ≤ 25 (OFSET)
Contact Name:
Study Type:
Oncology - Breast
Study Status:
Open to Accrual
Principal investigator:
Robert Donegan, MD
IRB number :
2151828
Study Number:
NRG-BR009
Phone:
Fax:
A021806, A phase III trial of perioperative versus adjuvant chemotherapy for resectable pancreatic cancer
Contact Name:
Steven Schmitt
Study Type:
Oncology - Gastrointestinal
Study Status:
Open to Accrual
Principal investigator:
Zhuoyan, Li, MD
IRB number :
1793748
Study Number:
A021806
Phone:
Fax:
For more information about this clinical trial, please visit the following link: https://clinicaltrials.gov/study/NCT04340141
ACRUE: A Prospective, Open-Label, Single-Arm, Phase II Study of Acalabrutinib and Rituximab in Untreated Elderly and/or Frail Patients With Diffuse Large B-Cell Lymphoma
Contact Name:
Study Type:
Oncology - Leukemia/Lymphoma/Myeloma
Study Status:
Open to Accrual
Principal investigator:
Zhuoyan, Li, MD
IRB number :
2146677
Study Number:
ACRUE (G2315)
Phone:
Fax:
For more information about this clinical trial, please visit the following link: https://clinicaltrials.gov/study/NCT05952024
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Contact Name:
Steven Schmitt
Study Type:
Oncology - Pulmonary
Study Status:
Suspended
Principal investigator:
Mei Tang, MD
IRB number :
669209
Study Number:
A151216
Phone:
Fax:
For more information about this clinical trial, please visit the following link: https://clinicaltrials.gov/study/NCT02194738
Alliance A031702, A phase II study of Ipilimumab, CabOzantinib, and NIvolumab in rare genitourinary Cancers
Contact Name:
Steven Schmitt
Study Type:
Oncology - Genitourinary
Study Status:
Open to Accrual
Principal investigator:
Ari Elman, MD
IRB number :
1857033
Study Number:
A031702
Phone:
Fax:
For more information about this clinical trial, please visit the following link: https://clinicaltrials.gov/study/NCT03866382